Joshua Meyers1, Michael Carter1, N Yi Mok1, Nathan Brown1. 1. Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK.
Abstract
AIM: Many medicinal chemistry-relevant structures and core scaffolds tend toward geometric planarity, which hampers the optimization of physicochemical properties desirable in drug-like molecules. As challenging drug target classes emerge, the exploitation of molecular three-dimensionality in lead optimization is becoming increasingly important. While recent interest has emphasized the importance of enhanced three-dimensionality in molecular fragment designs, the extent to which this is required in core scaffolds remains unclear. MATERIALS & METHODS: Three computational methods, Scaffold Tree deconstruction, Synthetic Disconnection Rules retrosynthetic deconstruction and virtual library enumeration, are applied, together with the descriptors plane of best fit and principal moments of inertia, to investigate the origins of three-dimensionality in drug-like molecules. CONCLUSION: This study informs on the stage at which molecular three-dimensionality should be considered in drug design.
AIM: Many medicinal chemistry-relevant structures and core scaffolds tend toward geometric planarity, which hampers the optimization of physicochemical properties desirable in drug-like molecules. As challenging drug target classes emerge, the exploitation of molecular three-dimensionality in lead optimization is becoming increasingly important. While recent interest has emphasized the importance of enhanced three-dimensionality in molecular fragment designs, the extent to which this is required in core scaffolds remains unclear. MATERIALS & METHODS: Three computational methods, Scaffold Tree deconstruction, Synthetic Disconnection Rules retrosynthetic deconstruction and virtual library enumeration, are applied, together with the descriptors plane of best fit and principal moments of inertia, to investigate the origins of three-dimensionality in drug-like molecules. CONCLUSION: This study informs on the stage at which molecular three-dimensionality should be considered in drug design.
Entities:
Keywords:
drug-like molecules; library enumeration; molecular shape; molecular three-dimensionality; plane of best fit; principal moments of inertia; scaffolds; ternary density plots
Authors: Ansgar Schuffenhauer; Peter Ertl; Silvio Roggo; Stefan Wetzel; Marcus A Koch; Herbert Waldmann Journal: J Chem Inf Model Date: 2007 Jan-Feb Impact factor: 4.956
Authors: Andrew D Morley; Angelo Pugliese; Kristian Birchall; Justin Bower; Paul Brennan; Nathan Brown; Tim Chapman; Martin Drysdale; Ian H Gilbert; Swen Hoelder; Allan Jordan; Steven V Ley; Andy Merritt; David Miller; Martin E Swarbrick; Paul G Wyatt Journal: Drug Discov Today Date: 2013-07-30 Impact factor: 7.851
Authors: Sravan K Jonnalagadda; Bader I Huwaimel; Shirisha Jonnalagadda; Jered C Garrison; Paul C Trippier Journal: J Org Chem Date: 2022-03-08 Impact factor: 4.354
Authors: Thuy Nguyen; Thomas F Gamage; Ann M Decker; David B Finlay; Tiffany L Langston; Daniel Barrus; Michelle Glass; Danni L Harris; Yanan Zhang Journal: Bioorg Med Chem Date: 2021-05-12 Impact factor: 3.461
Authors: Hoan Vu; Liliana Pedro; Tin Mak; Brendan McCormick; Jessica Rowley; Miaomiao Liu; Angela Di Capua; Billy Williams-Noonan; Ngoc B Pham; Rebecca Pouwer; Bao Nguyen; Katherine T Andrews; Tina Skinner-Adams; Jessica Kim; Wim G J Hol; Raymond Hui; Gregory J Crowther; Wesley C Van Voorhis; Ronald J Quinn Journal: ACS Infect Dis Date: 2018-03-03 Impact factor: 5.084
Authors: Christine N Morrison; Kathleen E Prosser; Ryjul W Stokes; Anna Cordes; Nils Metzler-Nolte; Seth M Cohen Journal: Chem Sci Date: 2019-12-12 Impact factor: 9.969
Authors: Sara E Kearney; Gergely Zahoránszky-Kőhalmi; Kyle R Brimacombe; Mark J Henderson; Caitlin Lynch; Tongan Zhao; Kanny K Wan; Zina Itkin; Christopher Dillon; Min Shen; Dorian M Cheff; Tobie D Lee; Danielle Bougie; Ken Cheng; Nathan P Coussens; Dorjbal Dorjsuren; Richard T Eastman; Ruili Huang; Michael J Iannotti; Surendra Karavadhi; Carleen Klumpp-Thomas; Jacob S Roth; Srilatha Sakamuru; Wei Sun; Steven A Titus; Adam Yasgar; Ya-Qin Zhang; Jinghua Zhao; Rodrigo B Andrade; M Kevin Brown; Noah Z Burns; Jin K Cha; Emily E Mevers; Jon Clardy; Jason A Clement; Peter A Crooks; Gregory D Cuny; Jake Ganor; Jesus Moreno; Lucas A Morrill; Elias Picazo; Robert B Susick; Neil K Garg; Brian C Goess; Robert B Grossman; Chambers C Hughes; Jeffrey N Johnston; Madeleine M Joullie; A Douglas Kinghorn; David G I Kingston; Michael J Krische; Ohyun Kwon; Thomas J Maimone; Susruta Majumdar; Katherine N Maloney; Enas Mohamed; Brian T Murphy; Pavel Nagorny; David E Olson; Larry E Overman; Lauren E Brown; John K Snyder; John A Porco; Fatima Rivas; Samir A Ross; Richmond Sarpong; Indrajeet Sharma; Jared T Shaw; Zhengren Xu; Ben Shen; Wei Shi; Corey R J Stephenson; Alyssa L Verano; Derek S Tan; Yi Tang; Richard E Taylor; Regan J Thomson; David A Vosburg; Jimmy Wu; William M Wuest; Armen Zakarian; Yufeng Zhang; Tianjing Ren; Zhong Zuo; James Inglese; Sam Michael; Anton Simeonov; Wei Zheng; Paul Shinn; Ajit Jadhav; Matthew B Boxer; Matthew D Hall; Menghang Xia; Rajarshi Guha; Jason M Rohde Journal: ACS Cent Sci Date: 2018-12-05 Impact factor: 14.553